SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-145993
Filing Date
2014-04-16
Accepted
2014-04-16 17:04:01
Documents
3
Period of Report
2014-05-29
Effectiveness Date
2014-04-16

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d711314ddef14a.htm DEF 14A 584747
2 GRAPHIC g711314dsp_032.jpg GRAPHIC 52340
3 GRAPHIC g711314dsp_033.jpg GRAPHIC 54301
  Complete submission text file 0001193125-14-145993.txt   733326
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 14767985
SIC: 3841 Surgical & Medical Instruments & Apparatus